Cardiology
A new study suggests that gut microbes could affect stroke severity or post-stroke outcome through a metabolite called TMAO.
New therapeutic strategies that rely on TLR4 inhibition can counteract the formation of coronary clots in people with cardiovascular disease.
Researchers have developed molecules that remodel the gut microbiota to a healthier state, reducing cholesterol levels and inhibiting atherosclerosis.
Researchers have identified a microbial metabolite linked to events such as heart attack and stroke. The findings could lead to new ways to diagnose, prevent, and treat heart disease.
People with obesity-related conditions may benefit from supplements of the gut commensal Akkermansia muciniphila, a recent study suggests.
